Acetic acid, lead salt,basic

1. 1.1 IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING Product identifiers Product name Product Number Brand Index-No. CAS-No. : : : : : Lead(II) acetate basic 32306 Fluka 082-007-00-9 51404-69-4 1.2 Relevant identified uses of the substance or mixture and uses advised against Identified uses : Laboratory chemicals, Manufacture of substances 2. 2.1 2.2 HAZARDS IDENTIFICATION Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP] Carcinogenicity (Category 2) Reproductive toxicity (Category 1A) Specific target organ toxicity - repeated exposure (Category 2) Acute aquatic toxicity (Category 1) Chronic aquatic toxicity (Category 1) Classification according to EU Directives 67/548/EEC or 1999/45/EC Limited evidence of a carcinogenic effect. May cause harm to the unborn child. Possible risk of impaired fertility. Harmful: danger of serious damage to health by prolonged exposure if swallowed. Danger of cumulative effects. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. Label elements Labelling according Regulation (EC) No 1272/2008 [CLP] Pictogram Signal word Hazard statement(s) H351 H360Df H373 H410 Danger Suspected of causing cancer. May damage the unborn child. Suspected of damaging fertility. May cause damage to organs through prolonged or repeated exposure. Very toxic to aquatic life with long lasting effects. Precautionary statement(s) P201 P273 P281 P308 + P313 P501 Supplemental Hazard Obtain special instructions before use. Avoid release to the environment. Use personal protective equipment as required. IF exposed or concerned: Get medical advice/ attention. Dispose of contents/ container to an approved waste disposal plant. none Statements Restricted to professional users. According to European Directive 67/548/EEC as amended. Hazard symbol(s) R-phrase(s) R61 R48/22 R33 R40 R50/53 R62 S-phrase(s) S53 S45 S60 S61 May cause harm to the unborn child. Also harmful: danger of serious damage to health by prolonged exposure if swallowed. Danger of cumulative effects. Limited evidence of a carcinogenic effect. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. Possible risk of impaired fertility. Avoid exposure - obtain special instructions before use. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). This material and its container must be disposed of as hazardous waste. Avoid release to the environment. Refer to special instructions/ Safety data sheets. Restricted to professional users. 2.3 3. 3.1 Other hazards - none COMPOSITION/INFORMATION ON INGREDIENTS Substances Component Lead acetate Concentration CAS-No. EC-No. Index-No. 51404-69-4 215-630-3 082-007-00-9 - 4. 4.1 FIRST AID MEASURES Description of first aid measures General advice Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In case of skin contact Wash off with soap and plenty of water. Consult a physician. In case of eye contact Flush eyes with water as a precaution. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 4.2 4.3 5. 5.1 5.2 5.3 5.4 6. 6.1 6.2 6.3 6.4 7. 7.1 7.2 7.3 Most important symptoms and effects, both acute and delayed Lead salts have been reported to cross the placenta and to induce embryo- and feto- mortality. They also have teratogenic effect in some animal species. No teratogenic effects have been reported with exposure to organometallic lead compounds. Adverse effects of lead on human reproduction, embryonic and fetal development, and postnatal (e.g., mental) development have been reported. Excessive exposure can affect blood, nervous, and digestive systems. The synthesis of hemoglobin is inhibited and results in anemia. If left untreated, neuromuscular dysfunction, possible paralysis, and encephalopathy can result. Additional symptoms of overexposure include: joint and muscle pain, weakness of the extensor muscles (frequently the hand and wrist), headache, dizziness, abdominal pain, diarrhea, constipation, nausea, vomiting, blue line on the gums, insomnia, and metallic taste. High body levels produce increased cerebrospinal pressure, brain damage, and stupor leading to coma and often death., Anorexia., Vomiting, Convulsions, permanent brain damage Indication of any immediate medical attention and special treatment needed no data available FIREFIGHTING MEASURES Extinguishing media Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special hazards arising from the substance or mixture no data available Advice for firefighters Wear self contained breathing apparatus for fire fighting if necessary. Further information no data available ACCIDENTAL RELEASE MEASURES Personal precautions, protective equipment and emergency procedures Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. Environmental precautions Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. Methods and materials for containment and cleaning up Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal. Reference to other sections For disposal see section 13. HANDLING AND STORAGE Precautions for safe handling Avoid contact with skin and eyes. Avoid formation of dust and aerosols.Avoid exposure - obtain special instructions before use. Provide appropriate exhaust ventilation at places where dust is formed. Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Specific end uses no data available 8. 8.1 8.2 9. 9.1 EXPOSURE CONTROLS/PERSONAL PROTECTION Control parameters Components with workplace control parameters Exposure controls Appropriate engineering controls Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. Personal protective equipment Eye/face protection Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it. Immersion protection Material: Nitrile rubber Minimum layer thickness: 0,11 mm Break through time: > 480 min Material tested:Dermatril? ( Z677272, Size M) Splash protection Material: Nitrile rubber Minimum layer thickness: 0,11 mm Break through time: > 30 min Material tested:Dermatril? ( Z677272, Size M) data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 873000, e-mail sales@kcl.de, test method: EN374 If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the supplier of the CE approved gloves. This recommendation is advisory only and must be evaluated by an Industrial Hygienist familiar with the specific situation of anticipated use by our customers. It should not be construed as offering an approval for any specific use scenario. Body Protection impervious clothing, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). PHYSICAL AND CHEMICAL PROPERTIES Information on basic physical and chemical properties a) b) c) d) Appearance Odour Odour Threshold pH Form: powder Colour: white no data available no data available no data available e) f) g) h) Melting point/freezing point Initial boiling point and boiling range Flash point Evaporation rate no data available no data available no data available no data available i) Flammability (solid, gas) no data available j) k) l) Upper/lower flammability or explosive limits Vapour pressure Vapour density no data available no data available no data available m) Relative density no data available n) o) p) q) r) s) t) Water solubility Partition coefficient: n- octanol/water Autoignition temperature Decomposition temperature Viscosity Explosive properties Oxidizing properties soluble no data available no data available no data available no data available no data available no data available 9.2 Other safety information Bulk density 2.400 g/l 10. 10.1 10.2 10.3 10.4 10.5 10.6 11. 11.1 STABILITY AND REACTIVITY Reactivity no data available Chemical stability no data available Possibility of hazardous reactions no data available Conditions to avoid no data available Incompatible materials no data available Hazardous decomposition products no data available TOXICOLOGICAL INFORMATION Information on toxicological effects Acute toxicity no data available Skin corrosion/irritation no data available Serious eye damage/eye irritation no data available Respiratory or skin sensitization no data available Germ cell mutagenicity no data available Carcinogenicity Limited evidence of carcinogenicity in animal studies IARC: IARC: IARC: 2B - Group 2B: Possibly carcinogenic to humansRe-evaluation of inorganic lead compounds, IARC Monograph (Vol. 87) (February 2004) (Lead acetate) 3 - Group 3: Not classifiable as to its carcinogenicity to humansRe-evaluation of organic lead compounds, IARC Monograph (Vol. 87) (February 2004) (Lead acetate) 2A - Group 2A: Probably carcinogenic to humans (Lead acetate) 2A - Group 2A: Probably carcinogenic to humans (Lead acetate) 2B - Group 2B: Possibly carcinogenic to humansRe-evaluation of inorganic lead compounds, IARC Monograph (Vol. 87) (February 2004) (Lead acetate) 3 - Group 3: Not classifiable as to its carcinogenicity to humansRe-evaluation of organic lead compounds, IARC Monograph (Vol. 87) (February 2004) (Lead acetate) 2A - Group 2A: Probably carcinogenic to humans (Lead acetate) 2A - Group 2A: Probably carcinogenic to humans (Lead acetate) 2B - Group 2B: Possibly carcinogenic to humansRe-evaluation of inorganic lead compounds, IARC Monograph (Vol. 87) (February 2004) (Lead acetate) 3 - Group 3: Not classifiable as to its carcinogenicity to humansRe-evaluation of organic lead compounds, IARC Monograph (Vol. 87) (February 2004) (Lead acetate) 2A - Group 2A: Probably carcinogenic to humans (Lead acetate) 2A - Group 2A: Probably carcinogenic to humans (Lead acetate) Reproductive toxicity Known human reproductive toxicant Specific target organ toxicity - single exposure no data available Specific target organ toxicity - repeated exposure no data available Aspiration hazard no data available Potential health effects Inhalation Ingestion Skin Eyes May be harmful if inhaled. May cause respiratory tract irritation. May be harmful if swallowed. May be harmful if absorbed through skin. May cause skin irritation. May cause eye irritation. Signs and Symptoms of Exposure Lead salts have been reported to cross the placenta and to induce embryo- and feto- mortality. They also have teratogenic effect in some animal species. No teratogenic effects have been reported with exposure to organometallic lead compounds. Adverse effects of lead on human reproduction, embryonic and fetal development, and postnatal (e.g., mental) development have been reported. Excessive exposure can affect blood, nervous, and digestive systems. The synthesis of hemoglobin is inhibited and results in anemia. If left untreated, neuromuscular dysfunction, possible paralysis, and encephalopathy can result. Additional symptoms of overexposure include: joint and muscle pain, weakness of the extensor muscles (frequently the hand and wrist), headache, dizziness, abdominal pain, diarrhea, constipation, nausea, vomiting, blue line on the gums, insomnia, and metallic taste. High body levels produce increased cerebrospinal pressure, brain damage, and stupor leading to coma and often death., Anorexia., Vomiting, Convulsions, permanent brain damage Additional Information RTECS: Not available 12. 12.1 12.2 12.3 12.4 12.5 12.6 13. 13.1 14. 14.1 ECOLOGICAL INFORMATION Toxicity no data available Persistence and degradability no data available Bioaccumulative potential no data available Mobility in soil no data available Results of PBT and vPvB assessment no data available Other adverse effects Very toxic to aquatic life. DISPOSAL CONSIDERATIONS Waste treatment methods Product Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Contaminated packaging Dispose of as unused product. TRANSPORT INFORMATION UN number 14.2 ADR/RID: 2291 UN proper shipping name IMDG: 2291 IATA: 2291 ADR/RID: IMDG: IATA: LEAD COMPOUND, SOLUBLE, N.O.S. (Lead acetate) LEAD COMPOUND, SOLUBLE, N.O.S. (Lead acetate) Lead compound, soluble, n.o.s. (Lead acetate) 14.3 Transport hazard class(es) 14.4 14.5 14.6 15. ADR/RID: 6.1 Packaging group ADR/RID: III Environmental hazards ADR/RID: no Special precautions for user no data available REGULATORY INFORMATION IMDG: 6.1 IMDG: III IMDG Marine pollutant: yes IATA: 6.1 IATA: III IATA: no This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 15.1 15.2 Safety, health and environmental regulations/legislation specific for the substance or mixture no data available Chemical Safety Assessment no data available 16. OTHER INFORMATION Further information The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information this document is based on the resent state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. Lookchem shall not be held liable for any damage resulting from handling or from contact with the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale.

Related Product

• 51404-70-7
• 51404-71-8
• 51404-72-9
• 51404-74-1
• 51404-76-3
• 5140-50-1
• 51405-71-1
• 51407-12-6
• 51407-18-2
• 51407-20-6
• 51407-21-7
• 5140-72-7

Recommended suppliers